In 2016, Proteon Pharmaceuticals signed the agreements for the co-financing five research projects from the European Union for Euro 3.2 million. The projects are for research and development of new generation, innovative products, based on our unique phage-platform technology. Conducting those projects will allow Proteon Pharmaceuticals to extend its product portfolio.

One of the projects, funded by Operational Program SMART GROWTH 2014-2020, co-finances the establishment of a modern Research and Development Center for bacteriophage preparations. Based on the new facility Proteon Pharmaceuticals will increase its research capacity as well as its production capacity.

To find out more about the projects please visit https://www.proteonpharma.com/research-and-development.